Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Along with the increase in life expectancy over the last century comes the increased risk for development of age-related disorders, including metabolic and neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases. These chronic disorders share two main characteristics: 1) neuronal loss in motor, sensory or cognitive systems, leading to cognitive and motor decline; and 2) a strong correlation between metabolic changes and neurodegeneration. In order to treat them, a better understanding of their complexity is required: it is necessary to interpret the neuronal damage in light of the metabolic changes, and to find the disrupted link between the peripheral organs governing energy metabolism and the CNS. This review is an attempt to present ghrelin as part of molecular regulatory interface between energy metabolism, neuroendocrine and neurodegenerative processes. Ghrelin takes part in lipid and glucose metabolism, in higher brain functions such as sleep-wake state, learning and memory consolidation; it influences mitochondrial respiration and shows neuroprotective effect. All these make ghrelin an attractive target for development of biomarkers or therapeutics for prevention or treatment of disorders, in which cell protection and recruitment of new neurons or synapses are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
Fanselow, M. S., & Dong, H.-W. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.031 · Cited by 3,358 · cited 2×
“The dorsal hippocampus (DHPC) is associated with the control of learning/memory related to visuospatial processing (Fanselow and Dong, 2010), therefore ghrelin signalling in DHPC improves spatial memory performance (Chen et al., 2011).”
BackgroundPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940 · cited 5×
“The temporal patterns of ghrelin release are reciprocal to insulin but in a phase with leptin: ghrelin and leptin decrease after meals (Cummings et al., 2001).”
BackgroundInfluentialHypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804 · cited 2×
“circuitry is a component of the flip-flop switch for sleep/wake control (Saper et al., 2005).”
BackgroundStages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 2×
“atively late, in stage III of the disease (Braak et al., 2004), after 70–80% loss of striatal DA.”
BackgroundAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 10×
“Chronic NDDwhich include Alzheimer's (AD), Parkinson's (PD), and Huntington's (HD) diseases are progressive, associated with high morbidity andmortality because, so far, there are very limited to no options for their treatment.”
BackgroundInfluentialLees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 5×
“BDNF is the most prevalent growth factor in CNS (Barde et al., 1982), strong regulator of neuronal development and synaptic plasticity, well known for its role in the disease pathology (Autry and Monteggia, 2012).”
BackgroundInfluentialSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 1×
“Since insulin, IGF-1, insulin-receptors, and the signalling mechanisms are impaired in AD brain, this entity resembles DM and for that reason Steen et al. (2005) proposed the term “Type 3 Diabetes”.”
BackgroundCowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679
Mechanisms by which mitochondria transport calcium
Gunter, T. E., & Pfeiffer, D. R. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.5.c755 · Cited by 1,640 · cited 2×
“, 2000) which leads to activation of a cascade of reactions such as induction of non-specific permeabilization of the inner mitochondrial membrane (Gunter and Pfeiffer, 1990), uncoupling respiration from ATP synthesis, release of cytochrome-c, apoptosis inducing factor and pro-caspase (Green and Reed, 1998).”
BackgroundBrain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390 · cited 2×
“, 1982), strong regulator of neuronal development and synaptic plasticity, well known for its role in the disease pathology (Autry and Monteggia, 2012).”
BackgroundOrexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234 · cited 1×
“On the other hand, central administration of NPY (Szentirmai and Krueger, 2006) and orexin (Hagan et al., 1999) has the same effect.”
BackgroundCoexpression of Agrp and NPY in fasting-activated hypothalamic neurons
Hahn, T. M., Breininger, J. F., Baskin, D. G., & Schwartz, M. W. (1998) · Nature Neuroscience · doi:10.1038/1082 · Cited by 1,164 · cited 4×
“AgRP was detected in 94% of NPY neurons (Hahn et al., 1998) and their activation initiates feeding (Cummings et al., 2001).”
BackgroundInfluentialSaper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., & Lu, B. (1996) · Nature · doi:10.1038/381706a0 · Cited by 1,106 · cited 2×
“synaptic plasticity (Figurov et al., 1996), as well as ghrelin (Diano et al.”
BackgroundExpression of ghrelin receptor mRNA in the rat and the mouse brain
Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., & Elmquist, J. K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20823 · Cited by 1,074 · cited 1×
“GHSR1 is expressed in SCN master clock (Zigman et al., 2006) and in brain regions activated in anticipation of scheduled meals.”
BackgroundNagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · cited 1×
“BDNF promotes neuronal differentiation and survival therefore BDNF-deficiency may contribute to the impaired hippocampal neurogenesis (Rossi et al., 2006) associated with diverse diseases including AD (Nagahara et al., 2009).”
BackgroundAbizaid, A., Liu, Z.-W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., Roth, R. H., Sleeman, M. W., Picciotto, M. R., Tschöp, M. H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29867 · Cited by 984 · cited 2×
“Peripheral ghrelin injections increase spine density in the hippocampus (Berrout and Isokawa, 2012), hypothalamus (Pinto et al., 2004) and the ventral tegmental area, important for motivational aspects of multiple behaviours (Abizaid et al., 2006).”
BackgroundLee, J., Duan, W., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01085.x · Cited by 975
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · cited 2×
“Another factor probably implicated in pathogenesis of PD is BDNF because its levels are lower in SN (Murer et al., 2001) and conditional deletion of BDNF reduces the number of DA neurons (Baquet et al., 2005).”
BackgroundGhrelin controls hippocampal spine synapse density and memory performance
Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., da Silva, I., Horvath, B., Gaskin, F. S., Nonaka, N., Jaeger, L. B., Banks, W. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1656 · Cited by 828 · cited 3×
“BDNF is also implicated in the long-term potentiation and synaptic plasticity (Figurov et al., 1996), as well as ghrelin (Diano et al., 2006).”
BackgroundSchenck, C. H., & Mahowald, M. W. (2002) · SLEEP · doi:10.1093/sleep/25.2.120 · Cited by 770 · cited 1×
“RBD is characterised by dysfunction of systems that produce the normal REM atonia of sleep (Schenck and Mahowald, 2002) and is”
BackgroundMitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758 · cited 2×
“However, neither the normal function of htt nor the basis for such selective vulnerability is fully understood, although several mechanisms such as impaired energymetabolism (Gu et al., 1996), excitotoxicity (Beal et al.”
BackgroundUCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
Andrews, Z. B., Liu, Z.-W., Walllingford, N., Erion, D. M., Borok, E., Friedman, J. M., Tschöp, M. H., Shanabrough, M., Cline, G., Shulman, G. I., et al. (2008) · Nature · doi:10.1038/nature07181 · Cited by 710
Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
Mattson, M. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.005 · Cited by 640 · cited 4×
“026 pathway activates protein kinase C; phosphatidylinositol 3-kinase (PI3K) activates serine/threonine kinase AKT; and mitogen-activated protein kinase (MAPK) pathway activates several downstream effectors (Mattson, 2008).”
BackgroundInfluentialRossi, C., Angelucci, A., Costantin, L., Braschi, C., Mazzantini, M., Babbini, F., Fabbri, M. E., Tessarollo, L., Maffei, L., Berardi, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05059.x · Cited by 619
Figlewicz, D. P., Evans, S. B., Murphy, J., Hoen, M., & Baskin, D. G. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04087-8 · Cited by 482
The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas
Wierup, N., Svensson, H., Mulder, H., & Sundler, F. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00067-8 · Cited by 457
Levine, E. S., Crozier, R. A., Black, I. B., & Plummer, M. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10235 · Cited by 412 · cited 1×
“BDNF signals through tropomyosin-related kinase B (TrkB) receptor, leading to activation of three different intracellular pathways and augmentation of NMDAreceptor currents (Levine et al., 1998).”
BackgroundAndrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289
Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274 · cited 1×
“Additionally, transplantation of modified fibroblasts expressing BDNF into either the striatum or the midbrain attenuates induced DA neuron loss (Levivier et al., 1995), promotes functional recovery from the lesions, and corrects behavioural deficit (Mattson, 2008).”
BackgroundLiu, J., Prudom, C. E., Nass, R., Pezzoli, S. S., Oliveri, M. C., Johnson, M. L., Veldhuis, P., Gordon, D. A., Howard, A. D., Witcher, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2235 · Cited by 248 · cited 1×
“Acylation may be regulated independently of secretion by nutrient availability in the gut or by esterases cleaving the acyl group (Liu et al., 2008).”
BackgroundMoon, M., Kim, H. G., Hwang, L., Seo, J.-H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9037-x · Cited by 203 · cited 2×
“026 a survival factor for DA neurons by deactivating microglia and preserving mitochondrial respiration which makes it a valuable therapeutic agent for PD (Moon et al., 2009).”
BackgroundAndrews, Z. B., Horvath, B., Barnstable, C. J., Elseworth, J., Yang, L., Beal, M. F., Roth, R. H., Matthews, R. T., & Horvath, T. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4269-04.2005 · Cited by 199 · cited 9×
“Calcium overload also activates different enzymes involved in cell death and increases ROS production (Reynolds and Hastings, 1995).”
BackgroundInfluentialFontán-Lozano, Á., Sáez-Cassanelli, J. L., Inda, M. C., de los Santos-Arteaga, M., Sierra-Domínguez, S. A., López-Lluch, G., Delgado-García, J. M., & Carrión, Á. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2757-07.2007 · Cited by 195 · cited 1×
“These findings complement the in vivo obtained evidence, that elevated ghrelin during fasting enhances synaptic function NMDA-dependently (Fontán-Lozano et al., 2007).”
ResultSleep enhances nocturnal plasma ghrelin levels in healthy subjects
Dzaja, A., Dalal, M. A., Himmerich, H., Uhr, M., Pollmächer, T., & Schuld, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00527.2003 · Cited by 184 · cited 2×
“Contents lists available at ScienceDirect Neurobiology of Disease j ourna l homepage: www.e lsev ie r .com/ locate /ynbd i Review Ghrelin: A link between ageing, metabolism and neurodegenerative disorders I.I. Stoyanova ⁎”
BackgroundLynch, G., Kramar, E. A., Rex, C. S., Jia, Y., Chappas, D., Gall, C. M., & Simmons, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5113-06.2007 · Cited by 181 · cited 2×
“HD is particularly interesting NDD because of involvement of neurotrophic factors,mainly the BDNF signalling (Lynch et al., 2007).”
BackgroundDifferential expression of mRNA for leptin receptor isoforms in the rat brain
Guan, X.-M., Hess, J. F., Yu, H., Hey, P. J., & van der Ploeg, L. H. T. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00138-x · Cited by 173
Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.009 · Cited by 155
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus
Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151 · cited 1×
“Obesity and diabetes mellitus (DM) are associated with increased risk of developing dementia and AD (Moroz et al., 2008).”
BackgroundZheng, H., Corkern, M., Stoyanova, I., Patterson, L. M., Tian, R., & Berthoud, H.-R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00781.2002 · Cited by 135
Self-citationCORRESPONDENCE OF MELANIN-PIGMENTED NEURONS IN HUMAN BRAIN WITH A1–A14 CATECHOLAMINE CELL ROUPS
SAPER, C. B., & PETITO, C. K. (1982) · Brain · doi:10.1093/brain/105.1.87 · Cited by 107
Spiegel, K., Tasali, E., Leproult, R., Scherberg, N., & Van Cauter, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1978 · Cited by 106 · cited 3×
“elevation and declining towards the morning (Spiegel et al., 2011).”
BackgroundInfluentialUnger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5864-1 · Cited by 97
Schiavo‐Cardozo, D., Lima, M. M. O., Pareja, J. C., & Geloneze, B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12114 · Cited by 96
Patterson, Z. R., Ducharme, R., Anisman, H., & Abizaid, A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07310.x · Cited by 95 · cited 2×
“ninergic neurons projecting to it, whilst GHSR1-KOdisplays a decreased 5-HT activity (Patterson et al., 2010).”
BackgroundHorvath, T. L. (1997) · Endocrinology · doi:10.1210/endo.138.3.4976 · Cited by 68
Horvath, T. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01546.1998 · Cited by 62 · cited 1×
“Their location overlaps the area with hypothalamic projections from the suprachiasmatic nucleus (SCN), where the circadian clock resides and from the ventral lateral geniculate body (Horvath, 1997, 1998).”
Background
Cited by
Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., Fiorini, D., Boarelli, M. C., Rossi, G., & Eleuteri, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02587-2 · Cited by 453
Bonfili, L., Cecarini, V., Cuccioloni, M., Angeletti, M., Berardi, S., Scarpona, S., Rossi, G., & Eleuteri, A. M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0973-4 · Cited by 268
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease
de J.R. De-Paula, V., Forlenza, A. S., & Forlenza, O. V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.007 · Cited by 145
Central insulin modulates food valuation via mesolimbic pathways
Tiedemann, L. J., Schmid, S. M., Hettel, J., Giesen, K., Francke, P., Büchel, C., & Brassen, S. (2017) · Nature Communications · doi:10.1038/ncomms16052 · Cited by 113
Metadata
- Authors
- Stoyanova, I. I.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 72
- Pages
- 72-83
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2136137804
- Cited by
- 83
- References
- 53
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.